http://www.fpnotebook.com/
Diabetic Ketoacidosis Management in AdultsAka: DKA Management
- See Also
- Management: Phase 1 - Fluids in Adults (Emergent)
- Stabilize shock and Coma states first!
- Correct Volume Deficit
- Initial
- Give 1 liter NS bolus over first 45 minutes
- Repeat fluid bolus until shock corrected
- Next
- Protocol 1 (standard protocol)
- Replace first 50% volume deficit in first 8 hours
- Use Normal Saline or Lactated Ringers
- Replace remaining 50% deficit over next 16 hours
- Use D5 1/2 NS at 150-250 ml per hour
- Replace first 50% volume deficit in first 8 hours
- Protocol 2
- NS at 10 cc/kg/hr (+/- 5 cc/kg/hr)
- Until Serum Glucose <250 mg/dl
- Then D5 1/2NS with 20 kcl
- Give 150-250 cc/hour
- NS at 10 cc/kg/hr (+/- 5 cc/kg/hr)
- Protocol 3 (new protocol)
- Protocol uses 0.675% saline
- Administer 2.5 x maintenance rate
- Continue for 24 hours or until no acidosis
- Then administer 1 to 1.5 x maintenance rate
- Efficacy in children (compared with Protocol 1)
- Reduces fluid rate
- May decrease risk of cerebral edema
- Resulted in cost savings >$1000/patient
- Faster acidosis resolution
- Felner (2001) Pediatrics 108:735
- Reduces fluid rate
- Protocol 1 (standard protocol)
- Initial
- Precautions
- Do not drop Serum Osmolality (calc) >3 mOsms/hour
- Risk of cerebral edema
- Slow replacement if Fluid Overload risk
- Follow Intake and output closely
- Do not drop Serum Osmolality (calc) >3 mOsms/hour
- Management: Phase 2 - Acidosis, electrolytes in Adults
- Potassium Replacement
- Precautions
- Hypokalemia must be corrected prior to Insulin
- Hold Insulin until potassium >3.3 meq/L in adults
- Prerequisites
- Electrocardiogram without signs of Hyperkalemia
- Adequate urine output
- Administration: Adults
- Serum Potassium <3.3 meq/L
- Do not administer Insulin until potassium >3.3
- Give KCl 40 meq/hour IV until corrects
- Requires hourly recheck of Serum Potassium
- This is maximum IV potassium rate!
- Requires cardiac monitoring
- Serum Potassium 3.3 to 5.0 meq/L
- Standard replacement: 20-30 meq per liter
- Serum Potassium >5.0 meq/L
- Do not administer any potassium
- Monitor every 2 hours until <5.0
- Serum Potassium <3.3 meq/L
- Precautions
- Phosphate Replacement
- Indications
- Serum Phosphorus < 0.5-1.0 mg/dl (Severe Depletion)
- Controversial - May not be required
- Consider if cardiopulmonary adverse affects
- Contraindications
- Renal Insufficiency
- Administration
- Determine Potassium Replacement as above
- Replace part of potassium with potassium phosphate
- Potassium Phosphate: Replace one third potassium
- Potassium Chloride: Replace two thirds potassium
- Indications
- Magnesium Replacement
- Indications
- Symptomatic Hypomagnesemia (Magnesium <1 meq/L)
- Administration
- MgSO4 50%: 2.5-5.0 ml (20-40 meq) IM
- Indications
- Sodium Bicarbonate Replacement
- Indications
- ABG pH < 6.9 to 7.0 after initial hour of hydration
- Other contributing factors
- Shock or Coma
- Severe Hyperkalemia
- Administration
- Indications
- Potassium Replacement
- Management: Phase 3 - Blood Glucose Control
- Precautions
- Hypokalemia must be corrected prior to Insulin
- Adult Insulin protocol
- IV Insulin administration
- Initial
- Give IV bolus of 0.15 units/kg
- Start 0.1 units/kg/hour Insulin Drip
- Maintenance
- Anticipate Serum Glucose drop of 50-70 mg/dl/hour
- If inadequate drop, then increase drip
- Increase Insulin Infusion rate by 50-100%
- Continue at increased rate until adequate
- If inadequate drop, then increase drip
- When Serum Glucose <200-250 mg/dl
- Keep Serum Glucose at 150 to 200 mg/dl
- Decrease rate by 50% (to 0.05 units/kg) or
- Discontinue Insulin Drip and start SC dosing
- Anticipate Serum Glucose drop of 50-70 mg/dl/hour
- Initial
- IM or SC Insulin administration
- IV Insulin administration
- Glucose monitoring
- Glucose monitoring every 30 minutes to 1 hour
- Target glucose decrease 50-70 mg/dl/h
- Dextrose Administration
- Add 5% Dextrose to fluids when glucose < 250 mg/dl
- Precautions
- References
- Chiasson (2003) CMAJ 168:859
- Orland in Stine (1994) Emergency Med, p. 204-5
- Kitabchi (2001) Diabetes Care 24:131
- Trachtenbarg (2005) Am Fam Physician 71(9):1705
- Trence (2001) Endocrinol Metab Clin North Am 30:817
